Conference Coverage
Latest Content
Oct 13, 2026 | Commentary
Metastatic Breast Cancer: An NP and a Nurse-Patient on Hope and Honesty
Oral Vitamin C Misses Primary End Point in CCUS but Shows Survival Signal
Oct 12, 2026
Breast Cancer Awareness: An APN on Personalized Care and Survivorship
Oct 12, 2026
Navigation Boosts Cascade Genetic Testing in Relatives of BRCA Carriers
Oct 10, 2026
National PA Week: PA-Nurse Synergy Transforms Outpatient Hematology Care
Oct 09, 2026
Advertisement
Shorts
1:30
On-Body Injectors Arrive in Myeloma Care: What Nurses Need to Know
5 hours ago
by
By ONN Staff
1:31
MBC Awareness Day: What an NP and a Nurse-Patient Want Nurses to Know
a day ago
by
La-Urshalar Brock, MSN, FNP-BC, CNM
0:45
Navigators Helped 73% of Relatives of BRCA Carriers Complete Testing
2 days ago
by
Roni Nitecki Wilke, M.D., M.P.H.
1:31
FDA OKs Immunotherapy After Surgery for Stage 3 dMMR Colon Cancer
4 days ago
by
By ONN Staff
1:16
FDA Approves Maintenance Tucatinib Regimen for HER2+ Breast Cancer
5 days ago
by
By ONN Staff
1:17
FDA Approves Pirtobrutinib Tablets for First-Line Untreated CLL/SLL Care
8 days ago
by
By ONN Staff
0:47
How AI Speeds Contouring and Planning in Radiation Oncology
10 days ago
by
Suresh Rana, PhD
1:10
Psychedelics and Mortality in Cancer Care
15 days ago
by
Jason Konner, MD
1:06
FDA Approves Dual Belzutifan-Lenvatinib Therapy for Advanced Clear Cell RCC
18 days ago
by
By ONN Staff
0:48
Prioritizing Quality of Life in Prostate Cancer Care
18 days ago
by
Maggie O'Block, MSN, APRN-BC
Videos
All News
Advertisement
Advertisement
Adding atezolizumab to adjuvant FOLFOX halved the risk of recurrence or death in ATOMIC, with more grade 3 to 4 adverse events.
Real-time check-ins from patients with MBC showed quality of life dipped when depression, anxiety, or fatigue rose above usual levels.
FDA approves tucatinib maintenance with trastuzumab and pertuzumab for HER2+ breast cancer based on HER2CLIMB-05.
In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Following WCLC 2026, Katherine Kuhns details how perioperative immunotherapy, AI patient tools, and wearables are transforming thoracic surgical nursing care.
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Five-week hypofractionated radiation after prostatectomy showed similar 5-year cancer control and quality of life but more grade 3 urinary toxicity.
Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.
Advertisement
Dr. Wendy Harpham reflects on her journey as a physician and patient, emphasizing precise clinical communication in oncology care.
FDA approves pirtobrutinib for untreated CLL/SLL without 17p deletion based on BRUIN CLL-313 data. Read key nursing safety takeaways.
Most oral blood cancer drug prescriptions were first rejected by insurers, and fill rates fell sharply when out-of-pocket costs topped $175.
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.
Advertisement
Advertisement